Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy

Clinical trial NCT07340164 · RECRUITING

Trial details

NCT number: NCT07340164
Sponsor: Yonsei University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Carcinoma, Recurrent Ovarian Cancer Metastatic Recurrent Ovarian Cancer (OvCa)

Start date: 2026-02-26
Primary completion: 2026-12-30
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.